ArticleAge and ageing2025
Retrospective multi-centre cohort study of polypharmacy, the Drug Burden Index and associations with outcomes in older surgical inpatients.
Article in Age and ageing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComprehensive medication utilisation and its association with outcomes are not well described in older surgical inpatients.
objectivesInvestigate medication utilisation and the associations of the number of medications and exposure to anticholinergic and sedative medications measured using the Drug Burden Index (DBI exposure) with outcomes in older surgical inpatients.
methodsA multi-centre retrospective cohort study of surgical patients ≥65 years at five Australian hospitals admitted for ≥48 hours, from 4 January 2022 to 3 January 2023. The number of regular medications was counted on admission and discharge. DBI exposure throughout admission was calculated using the area under the curve for DBI/days of admission (AUC DBI/days). Multilevel regression was conducted for outcomes on/during admission [falls, adverse drug events (ADEs), delirium, pressure ulcers, Hospital Frailty Risk Score (HFRS), length of stay (LOS)].
resultsThe 13 815 participants (51.1% male) had a median (IQR) age of 77 (71-84) years. The median number of medications was 5 (2-9) on admission and 9 (6-13) on discharge. The median AUC DBI/days was 0.13 (0-0.5). The number of admission medications was associated with delirium [adjusted odds ratio (aOR) 1.02, 95% CI: 1.01-1.04], ADEs (aOR 1.03, 95% CI: 1.01-1.04), pressure ulcers (aOR 1.04, 95% CI:1.02-1.06), HFRS [adjusted rate ratio (aRR) 1.01, 95% CI:1.001-1.02] and increased LOS (aRR 1.011, 95% CI: 1.008-1.014). The AUC DBI/days was associated with falls (aOR 1.29, 95% CI: 1.18-1.41), delirium (aOR 1.63, 95% CI:1.46-1.82), ADEs (aOR 1.26, 95% CI: 1.11-1.43), pressure ulcers (OR 1.60, 95% CI: 1.38-1.86), HFRS (aRR 1.27, 95% CI:1.17-1.37) and increased LOS (aRR 1.36, 95% CI:1.32-1.40).
conclusionPolypharmacy is common amongst older surgical inpatients, and the number of medications increased from admission to discharge. Increased DBI exposure was associated with adverse outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.